Global Bnp And Ntprobnp Market Size 2024, Forecast To 2033
6 Mar, 2024
The bnp and ntprobnp market size has grown rapidly in recent years. It will grow from $1.77 billion in 2023 to $2 billion in 2024 at a compound annual growth rate (CAGR) of 13.2%. The growth in the historic period can be attributed to aging population, clinical utility in heart failure diagnosis, advancements in cardiovascular medicine, focus on preventive healthcare. The bnp and ntprobnp market size is expected to see rapid growth in the next few years. It will grow to $3.15 billion in 2028 at a compound annual growth rate (CAGR) of 12.1%. The growth in the forecast period can be attributed to increasing cardiovascular disease burden, integration into point-of-care testing, expanding applications in other medical conditions, personalized medicine approaches, telemedicine and remote monitoring. Major trends in the forecast period include technological advancements in assay methods, personalized medicine approaches, biomarker in predicting prognosis, emergence of novel biomarkers, global standardization efforts.
Global BNP And NTproBNP Market Key Driver
The rising prevalence of cardiovascular diseases is expected to propel the growth of the BNP and NTproBNP market going forward. Cardiovascular diseases are disorders that affect the heart and blood vessels, such as peripheral arterial disease, cerebrovascular disease, coronary heart disease, and others. BNP and NTproBNP tests deal with heart health and safety monitoring, determining factors contributing to the cardiovascular disease before disease occurrence, thereby helping in taking preventative measures and reducing the chance of mortality. For instance, in March 2022, according to the Office for National Statistics, a UK-based statistics authority that reports directly to the UK Parliament, the number of deaths due to a heart attack as an underlying cause increased from 19,440 in 2020 to 20,061 in 2021. The rising prevalence of cardiovascular diseases is driving the BNP and NTproBNP markets, with its market size in 2023 being the number of deaths due to a heart attack as an underlying cause increased from 19,440 in 2020 to 20,061 in 2021.
Get A Free Sample Of The Global BNP And NTproBNP Market ReportGlobal BNP And NTproBNP Market Segments
The bnp and ntprobnp market covered in this report is segmented –
1) By Type: BNP (Brain Natriuretic Peptide), NT-proBNP (N-terminal Pro–B-Type Natriuretic Peptide)
2) By Location Of Testing: Point Of Care Testing, Laboratory Testing
3) By Application: Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome (ACS), Other Applications
By Geography:The regions covered in the bnp and ntprobnp market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain
Asia-Pacific was the largest region in the BNP and NTproBNP market in 2023. North America is expected to be the fastest-growing region in the global BNP and NTproBNP market report during the forecast period. The regions covered in the bnp and ntprobnp market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Major BNP And NTproBNP Industry Players
Abbott Laboratories,Gentian Diagnostics ASA,Siemens AG,PerkinElmer Inc.,Biomerieux SA,Quidel Corporation,Bio-Rad Laboratories Inc.,F Hoffman La Roche Ltd.,CTK Biotech Inc.,RayBiotech Life Inc.,BHR Pharmaceuticals Ltd.,Getein Biotech Inc.,VACURE Biotechnology Co. Ltd.,Bio-Techne Co.,Xiamen Biotime Biotechnology Co. Ltd.,Scripps Laboratories Inc.,Danaher Corporation,Beckman Coulter Inc.,Thermo Fisher Scientific Inc.,Randox Laboratories Ltd.,LSI Medience Corporation,Shionogi & Co. Ltd.,Radiometer Medical ApS,Ortho Clinical Diagnostics,Tosoh Corporation,Aidian Oy,Shenzhen Mindray Bio-Medical Electronics Co. Ltd.,Becton Dickinson and Company,Acon Laboratories Inc.,Response Biomedical Corp.,Nanomix Inc.,Cepheid Inc.,Alere Inc.
Get The Full Global BNP And NTproBNP Market Report
BNP And NTproBNP Market Overview
A BNP (B-type natriuretic peptide) and NT-proBNP (N-terminal Pro-brain Natriuretic Peptide) tests refer to a test that measures the amount of BNP or its prohormone NT-proBNP in the bloodstream, detecting heart failure and other heart-related ailments. BNP, or NT-proBNP, are natriuretic peptides that play a crucial role in regulating circulation. The high levels of BNP or NT-proBNP are indications of underlying heart disease (abnormality in pumping blood).
BNP And NTproBNP Global Market Report 2023 provides data on the global bnp and ntprobnp market such as market size, growth forecasts, segments and geographies, competitive landscape including leading competitors’ revenues, profiles and market shares. The bnp and ntprobnp market report identifies opportunities and strategies based on market trends and leading competitors’ approaches.